The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: A prospective review

Cancer

Volumn 83, Issue 4, 1998, Pages 726-731

  Obermair, Andreas ^a   Handisurya, Alessandra ^a   Kaider, Alexandra ^b   Sevelda, Paul ^a   Kölbl, Heinz ^a   Gitsch, Gerald ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anemia; Hemoglobin; Ovarian carcinoma; Prognosis

Indexed keywords

ADULT; ANEMIA; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HEMOGLOBIN ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0031812381     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U     Document Type: Article

References (24)

1. Moliterno AR, Spivak JL. Anemia of cancer. Hematol Oncol Clin North Am 1996;10:345-63.
2. Spivak JL. Cancer-related anemia: its causes and characteristics. Semin Oncol 1994;21:3-8.
3. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995;76:1302-12.
4. Werner Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc Jones H. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1309-17.
5. Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Preoperative radiotherapy for muscle-invasive bladder carcinoma: long term follow-up and prognostic factors for 338 patients. Cancer 1994;74:2819-27.
6. Dunphy EP, Petersen IA, Cox RS, Bagshaw MA. The influence of initial hemoglobin and blood perssure levels on results of radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1988;16:1173-8.
7. Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr., et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077-83.
8. Hong JH, Chen MS, Lin FJ, Tang SG. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 1992;22:913-7.
9. Serov SF, Scully RE, Sorbin LH. Histological typing of ovarian tumors. International Histological Classification of Tumors. No. 9. Geneva: World Health Organization, 1973:17.
10. Day TG, Gallager HS, Rutledge FN. Epithelial carcinoma of the ovary: the prognostic importance of histologic grade. Natl Cancer Inst Monogr 1975;42:15-21.
11. International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987;156:263-4.
12. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1985;53:457-81.
13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
14. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
15. Dische S. Radiotherapy and anemia: the clinical experience. Radiat Oncol 1991;20(Suppl):35-40.
16. Gonzalez Gonzalez D. Hypoxia and local tumour control. Part 1. Radiat Oncol 1991; 20(Suppl):5-7.
17. Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
18. Liang BC. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J Neural Oncol 1996;29:149-55.
19. Busch RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986;12:2047-50.
20. Leitgeb C, Pecherstorfer M, Fritz E, Ludwig H. Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 1994;73: 2535-42.
21. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogenic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-67.
22. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-6.
23. Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, et al. Recombinant human erythropoietin for the correction of cancer-associated anemia with and without concomitant cytotoxic chemotherapy. Cancer 1995;76:2319-29.
24. Henry DH, Thatcher N. Patient selection and predicting response to recombinant human erythropoietin in anemic cancer patients. Semin Hematol 1996;33(1 Suppl 1): 2-5.